multidrug resistance 1 gene
Recently Published Documents


TOTAL DOCUMENTS

95
(FIVE YEARS 5)

H-INDEX

23
(FIVE YEARS 1)

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Fredy E. Villena ◽  
Jorge L. Maguiña ◽  
Meddly L. Santolalla ◽  
Edwar Pozo ◽  
Carola J. Salas ◽  
...  

Abstract Background The high incidence of Plasmodium vivax infections associated with clinical severity and the emergence of chloroquine (CQ) resistance has posed a challenge to control efforts aimed at eliminating this disease. Despite conflicting evidence regarding the role of mutations of P. vivax multidrug resistance 1 gene (pvmdr1) in drug resistance, this gene can be a tool for molecular surveillance due to its variability and spatial patterns. Methods Blood samples were collected from studies conducted between 2006 and 2015 in the Northern and Southern Amazon Basin and the North Coast of Peru. Thick and thin blood smears were prepared for malaria diagnosis by microscopy and PCR was performed for detection of P. vivax monoinfections. The pvmdr1 gene was subsequently sequenced and the genetic data was used for haplotype and diversity analysis. Results A total of 550 positive P. vivax samples were sequenced; 445 from the Northern Amazon Basin, 48 from the Southern Amazon Basin and 57 from the North Coast. Eight non-synonymous mutations and three synonymous mutations were analysed in 4,395 bp of pvmdr1. Amino acid changes at positions 976F and 1076L were detected in the Northern Amazon Basin (12.8%) and the Southern Amazon Basin (4.2%) with fluctuations in the prevalence of both mutations in the Northern Amazon Basin during the course of the study that seemed to correspond with a malaria control programme implemented in the region. A total of 13 pvmdr1 haplotypes with non-synonymous mutations were estimated in Peru and an overall nucleotide diversity of π = 0.00054. The Northern Amazon Basin was the most diverse region (π = 0.00055) followed by the Southern Amazon and the North Coast (π = 0.00035 and π = 0.00014, respectively). Conclusion This study showed a high variability in the frequencies of the 976F and 1076L polymorphisms in the Northern Amazon Basin between 2006 and 2015. The low and heterogeneous diversity of pvmdr1 found in this study underscores the need for additional research that can elucidate the role of this gene on P. vivax drug resistance as well as in vitro and clinical data that can clarify the extend of CQ resistance in Peru.


2020 ◽  
Vol 114 (5) ◽  
pp. 339-345
Author(s):  
Adel Spotin ◽  
Mahmoud Mahami-Oskouei ◽  
Ehsan Ahmadpour ◽  
Mahdi Parsaei ◽  
Ali Rostami ◽  
...  

Abstract Background Chloroquine (CQ) is generally prescribed as the front-line antimalarial drug of choice to treat Plasmodium vivax infections; however, some clinical CQ-resistant P. vivax isolates have been indigenously reported around the world during the last decade. Methods In this study, P. vivax isolates (n=52) were obtained from autochthonous samples in southeast Iran during 2015–2017. The genomic DNA of samples was extracted, amplified (nested PCR) and sequenced by targeting the multidrug-resistance 1 gene. To verify the global genetic diversity of CQ-resistant P. vivax strains, the sequences of Pvmdr1 originating from Asia and the Americas were retrieved. Results A total of 46 haplotypes were grouped into three distinct geographical haplogroups. The haplotype diversity and occurrence rates of Pvmdr1 976F/1076L mutations indicate that the efficacy of CQ is being compromised in Mexico, China, Nicaragua, Thailand, Brazil (2016), Ethiopia, Mauritania (2012) and southwest India in the near future. The cladistic phylogenetic tree showed that Pvmdr1 sequences isolated from the southeast Asian clade has a partial sister relationship with the American clade. Conclusions The current findings will serve as a basis to develop appropriate malaria control strategies and public health policies in symptomatic imported malaria cases or plausible CQ-resistant P. vivax strains.


2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Huguette Gaelle Ngassa Mbenda ◽  
Meilian Wang ◽  
Jian Guo ◽  
Faiza Amber Siddiqui ◽  
Yue Hu ◽  
...  

2019 ◽  
Vol 47 (7) ◽  
pp. 2800-2809
Author(s):  
Qing Chang ◽  
Zhong-lin He ◽  
Yu-chong Peng ◽  
Shi-gang Duan ◽  
Yu-xin Dai ◽  
...  

Objective A relationship between polymorphisms rs1128503 and rs1045642 in the multidrug resistance 1 gene ( MDR1) and susceptibility to hepatocellular carcinoma (HCC) has been reported but is inconclusive. This study was performed to explore the significance of MDR1 polymorphisms rs1128503 and rs1045642 in screening and diagnosis of HCC. Methods Studies of association analyses between MDR1 gene polymorphisms rs1128503 and rs1045642 and HCC were selected from three foreign language databases (PubMed, Cochrane, and Embase) and three Chinese databases (Wanfang, China National Knowledge Infrastructure, and China Knowledge Network) and subjected to meta-analysis. Results We found no significant relationship between the rs1128503 polymorphism and susceptibility to HCC in 4 cohorts and no significant relationship between the rs1045642 polymorphism and susceptibility to HCC in 3 cohorts. Conclusions There was no relationship between polymorphisms rs1128503 or rs1045642 of the MDR1 gene and susceptibility to HCC.


2018 ◽  
Vol 64 ◽  
pp. 168-177 ◽  
Author(s):  
Veerayuth Kittichai ◽  
Wang Nguitragool ◽  
Huguette Gaelle Ngassa Mbenda ◽  
Jetsumon Sattabongkot ◽  
Liwang Cui

Author(s):  
R. Niruri ◽  
N.L. Ulandari ◽  
S.C. Yowani ◽  
I. Narayani ◽  
I. Narayani ◽  
...  

2017 ◽  
Vol 61 (12) ◽  
Author(s):  
Madeline Montenegro ◽  
Aaron T. Neal ◽  
Maritza Posada ◽  
Briegel De las Salas ◽  
Tatiana M. Lopera-Mesa ◽  
...  

ABSTRACT High treatment failure rates for Plasmodium falciparum malaria have been reported in Colombia for chloroquine, amodiaquine, and sulfadoxine-pyrimethamine. Artemisinin combination therapies were introduced in 2006 in Colombia, where artemether-lumefantrine (AL) is currently used to treat uncomplicated P. falciparum malaria. Artemisinin (ART) resistance was initially observed in Southeast Asia as an increased parasite clearance time, manifesting as a positive thick-blood smear on day 3 after treatment (D3 positivity). Recently, mutations in the propeller domain of the P. falciparum kelch13 gene (K13 propeller) have been associated with ART resistance. In this study, we surveyed AL effectiveness at D3 and molecular markers of drug resistance among 187 uncomplicated P. falciparum cases in 4 regions of Colombia from June 2014 to July 2015. We found that 3.2% (4/125) of patients showed D3 positivity, 100% (163/163) of isolates carried wild-type K13 propeller alleles, 12.9% (23/178) of isolates had multiple copies of the multidrug resistance 1 gene (mdr1), and 75.8% (113/149) of isolates harbored the double mutant NFSDD mdr1 haplotype (the underlining indicates mutant alleles). These data suggest that ART resistance is not currently suspected in Colombia but that monitoring for lumefantrine resistance and AL failures should continue.


2017 ◽  
Vol 117 (4) ◽  
pp. 849-855 ◽  
Author(s):  
Beata Smolarz ◽  
Dominik Skalski ◽  
Andrzej Rysz ◽  
Andrzej Marchel ◽  
Hanna Romanowicz ◽  
...  

2017 ◽  
Vol 37 (4) ◽  
pp. 531-536 ◽  
Author(s):  
Bart V. J. Cuppen ◽  
Katerina Pardali ◽  
Maarten C. Kraan ◽  
Anne C. A. Marijnissen ◽  
Linda Yrlid ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document